The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65)
- PMID: 12786677
- DOI: 10.1046/j.1464-5491.2003.00972.x
The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65)
Abstract
Aims: To develop a model for estimating the immediate and long-term healthcare costs associated with seven diabetes-related complications in patients with Type 2 diabetes participating in the UK Prospective Diabetes Study (UKPDS).
Methods: The costs associated with some major complications were estimated using data on 5102 UKPDS patients (mean age 52.4 years at diagnosis). In-patient and out-patient costs were estimated using multiple regression analysis based on costs calculated from the length of admission multiplied by the average specialty cost and a survey of 3488 UKPDS patients' healthcare usage conducted in 1996-1997.
Results: Using the model, the estimate of the cost of first complications were as follows: amputation pound 8459 (95% confidence interval pound 5295, pound 13 200); non-fatal myocardial infarction pound 4070 ( pound 3580, pound 4722); fatal myocardial infarction pound 1152 ( pound 941, pound 1396); fatal stroke pound 3383 ( pound 1935, pound 5431); non-fatal stroke pound 2367 ( pound 1599, pound 3274); ischaemic heart disease pound 1959 ( pound 1467, pound 2541); heart failure pound 2221 ( pound 1690, pound 2896); cataract extraction pound 1553 ( pound 1320, pound 1855); and blindness in one eye pound 872 ( pound 526, pound 1299). The annual average in-patient cost of events in subsequent years ranged from pound 631 ( pound 403, pound 896) for heart failure to pound 105 ( pound 80, pound 142) for cataract extraction. Non-in-patient costs for macrovascular complications were pound 315 ( pound 247, pound 394) and for microvascular complications were pound 273 ( pound 215, pound 343) in the year of the event. In each subsequent year the costs were, respectively, pound 258 ( pound 228, pound 297) and pound 204 ( pound 181, pound 255).
Conclusions: These results provide estimates of the immediate and long-term healthcare costs associated with seven diabetes-related complications.
Similar articles
-
The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).Diabet Med. 2015 Apr;32(4):459-66. doi: 10.1111/dme.12647. Epub 2015 Jan 7. Diabet Med. 2015. PMID: 25439048
-
Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany.Diabetes Care. 2018 May;41(5):971-978. doi: 10.2337/dc17-1763. Epub 2018 Jan 18. Diabetes Care. 2018. PMID: 29348194
-
Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up.Diabetes Care. 2020 Aug;43(8):1732-1740. doi: 10.2337/dc20-0072. Epub 2020 May 22. Diabetes Care. 2020. PMID: 32444454 Free PMC article.
-
Diabetes in Canada: direct medical costs of major macrovascular complications.Value Health. 2001 May-Jun;4(3):258-65. doi: 10.1046/j.1524-4733.2001.43017.x. Value Health. 2001. PMID: 11705187 Review.
-
Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain.Curr Med Res Opin. 2005 Oct;21(10):1617-29. doi: 10.1185/030079905X65349. Curr Med Res Opin. 2005. PMID: 16238902 Review.
Cited by
-
Burden of CKD and Cardiovascular Disease on Life Expectancy and Health Service Utilization: a Cohort Study of Hong Kong Chinese Hypertensive Patients.J Am Soc Nephrol. 2019 Oct;30(10):1991-1999. doi: 10.1681/ASN.2018101037. Epub 2019 Sep 6. J Am Soc Nephrol. 2019. PMID: 31492808 Free PMC article.
-
Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis.PLoS Med. 2010 Feb 23;7(2):e1000236. doi: 10.1371/journal.pmed.1000236. PLoS Med. 2010. PMID: 20186272 Free PMC article.
-
Cost Effectiveness of Treatments for Diabetic Retinopathy: A Systematic Literature Review.Pharmacoeconomics. 2019 Aug;37(8):995-1010. doi: 10.1007/s40273-019-00800-w. Pharmacoeconomics. 2019. PMID: 31012025
-
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial.Diabet Med. 2015 Jul;32(7):907-19. doi: 10.1111/dme.12711. Epub 2015 Apr 15. Diabet Med. 2015. PMID: 25661661 Free PMC article. Clinical Trial.
-
Hypothermia for perinatal asphyxia: trial-based resource use and costs at 6-7 years.Arch Dis Child Fetal Neonatal Ed. 2019 May;104(3):F285-F292. doi: 10.1136/archdischild-2017-314685. Epub 2018 Jul 11. Arch Dis Child Fetal Neonatal Ed. 2019. PMID: 29997167 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical